Country: United States
Language: English
Source: NLM (National Library of Medicine)
OFLOXACIN (UNII: A4P49JAZ9H) (OFLOXACIN - UNII:A4P49JAZ9H)
Cadila Pharmaceuticals Limited
OFLOXACIN
OFLOXACIN 200 mg
ORAL
PRESCRIPTION DRUG
To reduce the development of drug-resistant bacteria and maintain the effectiveness of ofloxacin tablets, USP and other antibacterial drugs, ofloxacin tablets, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ofloxacin tablets, USP are indicated for the treatment of adults with mild to moderate infections (unless otherwise indicated) caused by susceptible strains of the designated microorganisms in the infections listed below. Please see DOSAGE AND ADMINISTRATION for specific recommendations. Acute Bacterial Exacerbations of Chronic Bronchitis (ABECB) due to Haemophilus influenzae or Streptococcus pneumonia . Because fluoroquinolones, including ofloxacin, ha
Ofloxacin tablets USP, 200 mg are available as light yellow to yellow, oval, biconvex, film coated tablets, imprinted with “C213” in blue ink on one side and plain on the other side. They are available in bottles of 50, 100 and 500 tablets.. Bottles of 50 (NDC 71209-097-02) Bottles of 100 (NDC 71209-097-05) Bottles of 500 (NDC 71209-097-10) Ofloxacin tablets USP, 300 mg are available as white to off white, oval, biconvex, film coated tablets, imprinted with “C212” in blue ink on one side and plain on the other side.. They are available in bottles of 50, 100 and 500 tablets. Bottles of 50 (NDC 71209-098-02) Bottles of 100 (NDC 71209-098-05) Bottles of 500 (NDC 71209-098-10) Ofloxacin tablets USP, 400 mg are available as yellow to dark yellow, oval, biconvex, film coated tablets, imprinted with ‘C211’ in blue ink on one side and plain on other side. They are available in bottles of 50, 100 and 500 tablets. Bottles of 50 (NDC 71209-099-02) Bottles of 100 (NDC 71209-099-05) Bottles of 500 (NDC 71209-099-10) Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required) KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
Abbreviated New Drug Application
OFLOXACIN - OFLOXACIN TABLET, FILM COATED Cadila Pharmaceuticals Limited ---------- MEDICATION GUIDE MEDICATION GUIDE Ofloxacin Tablets, USP (oh-FLOX-a-sin) Rx only Read the Medication Guide that comes with ofloxacin before you start taking it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or your treatment. What is the most important information I should know about ofloxacin tablets? Ofloxacin belongs to a class of antibiotics called fluoroquinolones. Ofloxacin tablets can cause serious side effects. Some of these serious side effects can happen at the same time and could result in death. If you get any of the following serious side effects, get medical help right away. Talk with your healthcare provider about whether you should continue to take ofloxacin tablets. 1. Tendon rupture or swelling of the tendon (tendinitis). • Tendon problems can happen in people of all ages who take ofloxacin tablets. Tendons are tough cords of tissue that connect muscles to bones. • Pain, swelling, tears, and inflammation of tendons including the back of the ankle (Achilles), shoulder, hand, or other tendon sites. • The risk of getting tendon problems while you take ofloxacin tablets is higher if you: • are over 60 years of age • are taking steroids (corticosteroids) • have had a kidney, heart or lung transplant. • Tendon problems can happen in people who do not have the above risk factors when they take ofloxacin tablets. Other reasons that can increase your risk of tendon problems can include: • physical activity or exercise • kidney failure • tendon problems in the past, such as in people with rheumatoid arthritis (RA). • Stop taking ofloxacin immediately and get medical help right away at the first sign of tendon pain, swelling or inflammation. Stop taking ofloxacin tablets until tendinitis or tendon rupture has been ruled out by your healthcare provider. Avoid exercise and usin Read the complete document
OFLOXACIN - OFLOXACIN TABLET, FILM COATED CADILA PHARMACEUTICALS LIMITED ---------- RX ONLY WARNING SERIOUS ADVERSE REACTIONS INCLUDING TENDINITIS, TENDON RUPTURE, PERIPHERAL NEUROPATHY, CENTRAL NERVOUS SYSTEM EFFECTS AND EXACERBATION OF MYASTHENIA GRAVIS FLUOROQUINOLONES, INCLUDING OFLOXACIN, HAVE BEEN ASSOCIATED WITH DISABLING AND POTENTIALLY IRREVERSIBLE SERIOUS ADVERSE REACTIONS THAT HAVE OCCURRED TOGETHER, INCLUDING: • TENDINITIS AND TENDON RUPTURE • PERIPHERAL NEUROPATHY • CENTRAL NERVOUS SYSTEM EFFECTS (SEE WARNINGS). DISCONTINUE OFLOXACIN IMMEDIATELY AND AVOID THE USE OF FLUOROQUINOLONES, INCLUDING OFLOXACIN, IN PATIENTS WHO EXPERIENCE ANY OF THESE SERIOUS ADVERSE REACTIONS (SEE WARNINGS). • FLUOROQUINOLONES, INCLUDING OFLOXACIN, MAY EXACERBATE MUSCLE WEAKNESS IN PERSONS WITH MYASTHENIA GRAVIS. AVOID OFLOXACIN IN PATIENTS WITH A KNOWN HISTORY OF MYASTHENIA GRAVIS (SEE WARNINGS). •BECAUSE FLUOROQUINOLONES, INCLUDING OFLOXACIN, HAVE BEEN ASSOCIATED WITH SERIOUS ADVERSE REACTIONS (SEE WARNINGS), RESERVE OFLOXACIN FOR USE IN PATIENTS WHO HAVE NO ALTERNATIVE TREATMENT OPTIONS FOR THE FOLLOWING INDICATIONS: O ACUTE EXACERBATION OF CHRONIC BRONCHITIS O UNCOMPLICATED CYSTITIS (SEE INDICATIONS AND USAGE) To reduce the development of drug-resistant bacteria and maintain the effectiveness of ofloxacin tablets and other antibacterial drugs, ofloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Ofloxacin tablets are a synthetic broad-spectrum antimicrobial agent for oral administration. Chemically, ofloxacin, USP, a fluorinated carboxyquinolone, is the racemate, (±)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7_H_- pyrido[1,2,3-_de_]-1,4-benzoxazine-6-carboxylic acid. The chemical structure is: C H FN O M.W. 361.4 Ofloxacin, USP is an off-white to pale yellow crystalline powder. The molecule exists as a zwitterion at the pH conditions in the small intestine. The relative solubility characteristics Read the complete document